Dose Tracking System Optimizes Dose Management Like Never Before
WASHINGTON, D.C., March 28, 2014 – With the unmatched flexibility to measure radiation peak skin dose in real time, Toshiba America Medical Systems, Inc.’s Dose Tracking System is the latest advancement in optimizing dose management for its InfinixTM-i cardiovascular X-ray systems during adult and pediatric interventional procedures.
“We partnered with Toshiba to develop the Dose Tracking System to further improve the safety and well-being of patients during interventional procedures,” said Dr. Neil Dashkoff, clinical professor of medicine, University at Buffalo; director, Cardiac Catheterization Laboratory, Erie County Medical Center. “This user-friendly Dose Tracking System assists the operator to ‘spread the skin dose,’ minimizing the risk of deterministic skin injury to any given area. This is particularly important during long interventional procedures and in circumstances where the patient may return to the cath lab within a few months of the incident procedure.”
Toshiba’s Dose Tracking System displays live and cumulative radiation exposure through an intuitive, color-coded indicator on a 3D visual representation of the patient. The display shows where the radiation is being administered on the patient’s body in real time. This allows the clinician throughout a procedure to make quick and necessary changes to distribute the skin dose and minimize the potential risk of locally concentrated high exposure.
“We designed the Dose Tracking System in partnership with the University at Buffalo to provide hospitals with an easy-to-understand visual aid that shows how to suppress radiation exposure,” said David Sloop, director, X-ray Vascular Business Unit, Toshiba. “Combining the Dose Tracking System with other dose management tools, like Spot Fluoroscopy, Toshiba offers physicians better ways to optimize dose management when performing cardiac interventions.”
Toshiba will showcase the Dose Tracking System for the Infinix-i at this year’s American College of Cardiology (ACC) annual meeting in Washington, D.C., Mar. 29–31, 2014 (Booth #2323).
About Toshiba America Medical Systems, Inc.
With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at www.toshibamedicalsystems.com.
Toshiba is a world-leading diversified manufacturer, solutions provider and marketer of advanced electronic and electrical products and systems. Toshiba Group brings innovation and imagination to a wide range of businesses: digital products, including LCD TVs, notebook PCs, retail solutions and MFPs; electronic devices, including semiconductors, storage products and materials; industrial and social infrastructure systems, including power generation systems, smart community solutions, medical systems and escalators & elevators; and home appliances.
Toshiba was founded in 1875, and today operates a global network of more than 590 consolidated companies, with 206,000 employees worldwide and annual sales surpassing 5.8 trillion yen (US$61 billion). Visit Toshiba’s website at www.toshiba.co.jp/index.htm.
SOURCE: Toshiba Medical Systems Corporation